JPRN-UMIN000006190已完成未知
Observational study of HER2 positive rate in advanced or recurrent gastric cancer - Observational study of HER2 positive rate in advanced or recurrent gastric cancer (JFMC44-1101)
Japanese Foundation for Multidisciplinary Treatment of Cancer0 个研究点目标入组 1,200 人开始时间: 2011年9月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 1,200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •All patients who does not meet the key inclusion criteria
研究者
相似试验
已完成
不适用
Observational study of serum HER2 in HER2 positive advanced gastric cancer treated with trastuzumab in combination with capecitabine plus cisplatin(XP+H)Gastric cancerJPRN-UMIN000006445Sapporo Medical University 1st department of Internal Medicine10
已完成
不适用
Observational study of Serum HER2 in HER2 negative advanced gastric cancer treated with capecitabine plus cisplatin(XP)Gastric cancerJPRN-UMIN000006442Sapporo Medical University 1st department of Internal Medicine50
进行中（未招募）
不适用
Tailoring treatment for HER2-positive early breast cancerHER2-positive early breast cancerMalignant neoplasm of breastCancerISRCTN81408940Institute of Cancer Research720
招募中
不适用
A study for assessment of HER2 status using Gene-Protein Assay (GPA) in metastatic colorectal cancercolorectal cancerJPRN-UMIN000039751ational Cancer Center150
已完成
不适用
Prognostic significance of HER2 expression in patients with resectable gastric cancerGastric adenocarcinomaCancerISRCTN54802594Inje University Busan Paik Hospital782